Larvol Delta - Characterization-of-Hematologic-Adverse-Events-and-Infections-with-Mezigdomide-Carfilzomib-and-Dexamethasone-Mezikd-in-RelapsedRefractory-Multiple-Myeloma-RRMM-Phase-3-SUCCESSOR2-Trial

carfilzomib - Generic mfg.

dexamethasone - Generic mfg.

mezigdomide (CC-92480) - BMS

https://imsannual2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=TU1XRFNPTlIyMjY0Nw&PosterID=826510&rnd=0.4542078

Fredrik Schjesvold, MD, PhD

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next